MeTC7

• CAT Number: I042650
• CAS Number: 1817841-22-7
• Molecular Formula: C32H48BrN3O4
• Molecular Weight: 618.65
• Purity: ≥95%
• Synonyms: [(2R,5R,6R,9R,10R,13S)-6,10,18-trimethyl-5-[(2R)-6-methylheptan-2-yl]-17,19-dioxo-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docos-21-en-13-yl] 2-bromoacetate
• InChI: InChI=1S/C32H48BrN3O4/c1-20(2)8-7-9-21(3)23-10-11-24-29(23,4)14-13-25-30(5)15-12-22(40-26(37)19-33)18-31(30)16-17-32(24,25)36-28(39)34(6)27(38)35(31)36/h16-17,20-25H,7-15,18-19H2,1-6H3/t21-,22+,23-,24-,25-,29-,30-,31?,32?/m1/s1
• InChIKey: LBFDLJSQMPCWKK-YMNKQYQVSA-N
• SMILES: C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C24C=CC5([C@@]3(CC[C@@H](C5)OC(=O)CBr)C)N6N4C(=O)N(C6=O)C)C

MeTC7（Cat No.:I042650）is a small molecule compound that has shown potential in scientific research for its biological activity, particularly in the areas of cell signaling and cancer therapy. It is often explored for its ability to target specific molecular pathways involved in cell proliferation, apoptosis, and tumor growth. MeTC7 may function as an inhibitor or modulator of certain enzymes or receptors, influencing cellular processes critical for disease progression. Preclinical studies continue to evaluate its efficacy and mechanism of action, with the goal of developing it as a therapeutic agent for cancer and other disorders.